VCM
INBX icon

Voleon Capital Management’s Inhibrx INBX Stock Holding History

Voleon Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.53M Buy
58,358
+19,053
+48% +$1.91M 0.1% 200
2026
Q1 		$2.64M Buy
39,305
+24,297
+162% +$1.8M 0.06% 289
2025
Q4 		$1.19M Buy
+15,008
New +$1.02M 0.03% 409

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Voleon Capital Management's INBX Position: Q2 2026 in Review

Voleon Capital Management increased its Inhibrx (INBX) stake by 48% in Q2 2026, buying an estimated $1.91M and bringing the position to 58,358 shares worth $5.53M. The position accounts for 0.1% of the portfolio, ranked #200.

Voleon Capital Management first reported a position in INBX in Q4 2025 and has held it in 3 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Voleon Capital Management held 58,358 shares of Inhibrx worth $5.53M as of Q2 2026.
  • Voleon Capital Management bought 19,053 Inhibrx shares in Q2 2026, an estimated $1.91M.
  • Inhibrx made up 0.1% of Voleon Capital Management's portfolio in Q2 2026, its #200 holding.
  • Voleon Capital Management first reported a position in Inhibrx in Q4 2025 and has held it in 3 quarters since.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.